3 biotech companies name physician chief medical officers

Three biotechnology companies have named new chief medical officers.

Advertisement

Michael Vasconcelles, MD, has been appointed chief medical officer of ImmunoGen, according to a July 31 news release. He previously served as executive vice president of research, development and medical affairs and steps into this new role following the departure of Anna Berkenblit, MD.

BioXyTran named Leslie Ajayi, MD, PhD, interim chief medical officer and chief of the medical advisory board, according to a July 31 news release. He joins BioXyTran with over two decades of clinical and academic experience, specializing in internal medicine, cardiovascular medicine and clinical pharmacology.

Charisse Sparks, MD, was appointed chief medical officer of Inspire Medical Systems, according to a July 31 news release. She most recently served as chief medical officer of AppliedVR and previously sat on Inspire’s board of directors and nominating and corporate governance committee.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

The 2 KPIs that drive readmissions — and how hospitals act on them in real time

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenter: Nik Rao, Dexur

Advertisement

Next Up in Chief Medical Officers

Advertisement

Comments are closed.